{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:58Z","timestamp":1740136378331,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10072-023-07283-w","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T11:02:08Z","timestamp":1703674928000},"page":"2807-2810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Valentina","family":"Andreozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-8182","authenticated-orcid":false,"given":"Rocco","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Scannapieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"d\u2019Arco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Caterino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"De Marca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Di Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"issue":"12","key":"7283_CR1","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"R Gold","year":"2012","unstructured":"Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 367(12):1098\u20131107. https:\/\/doi.org\/10.1056\/NEJMoa1114287","journal-title":"N Engl J Med"},{"issue":"1","key":"7283_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1212\/cpj.0000000000000567","volume":"9","author":"EJ Fox","year":"2019","unstructured":"Fox EJ, Buckle GJ, Singer B, Singh V, Boster A (2019) Lymphopenia and DMTs for relapsing forms of MS: considerations for the treating neurologist. NeurolClinPract 9(1):53\u201363. https:\/\/doi.org\/10.1212\/cpj.0000000000000567","journal-title":"NeurolClinPract"},{"key":"7283_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107710","volume":"219","author":"C Dello Russo","year":"2021","unstructured":"Dello Russo C, Scott KA, Pirmohamed M (2021) Dimethyl fumarate induced lymphopenia in multiple sclerosis: a review of the literature. PharmacolTher 219:107710. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107710","journal-title":"PharmacolTher"},{"key":"7283_CR4","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1007\/s00415-021-10412-0","volume":"268","author":"M Lucchini","year":"2021","unstructured":"Lucchini M, Prosperini L, Buscarinu MC et al (2021) Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis. J Neurol 268:2238\u20132245. https:\/\/doi.org\/10.1007\/s00415-021-10412-0","journal-title":"J Neurol"},{"issue":"8","key":"7283_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1177\/1352458515608961","volume":"22","author":"EE Longbrake","year":"2016","unstructured":"Longbrake EE, Ramsbottom MJ, Cantoni C, Ghezzi L, Cross AH, Piccio L (2016) Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients. MultScler 22(8):1061\u20131070. https:\/\/doi.org\/10.1177\/1352458515608961","journal-title":"MultScler"},{"key":"7283_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fneur.2018.00005","volume":"9","author":"EA Mills","year":"2018","unstructured":"Mills EA, Ogrodnik MA, Plave A, Mao-Draayer Y (2018) Emerging understanding of the mechanism of action for dimethyl fumarate in the treatment of multiple sclerosis. Front Neurol 9:5. https:\/\/doi.org\/10.3389\/fneur.2018.00005","journal-title":"Front Neurol"},{"key":"7283_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103357","volume":"57","author":"A Dinoto","year":"2022","unstructured":"Dinoto A, Sartori A, Cheli M, Pasquin F, Baldini S, Bratina A, Bosco A, Manganotti P (2022) Lymphopenia during treatment with dimethyl fumarate in patients with multiple sclerosis: prevalence, predicting factors and clinical outcomes. MultSclerRelatDisord 57:103357. https:\/\/doi.org\/10.1016\/j.msard.2021.103357","journal-title":"MultSclerRelatDisord"},{"key":"7283_CR8","doi-asserted-by":"publisher","unstructured":"Sainz de la Maza S, Sabin Mu\u00f1oz J, Pilo de la Fuente B, Thuissard I, Andreu-V\u00e1zquez C, Gal\u00e1n S\u00e1nchez-Seco V, Salgado-C\u00e1mara P, Costa-Frossard L, Monreal E, Ayuso-Peralta L, Garc\u00eda-Vasco L, Garc\u00eda-Dom\u00ednguez JM, Mart\u00ednez-Gin\u00e9s ML, Mu\u00f1oz Fern\u00e1ndez C, D\u00edaz-D\u00edaz J, Oreja-Guevara C, G\u00f3mez-Moreno M, Mart\u00edn H, Rubio-Flores L, Blasco MR, Villar-Guimerans LM, Aladro Y; Dimethyl Fumarate Study Group (2022) Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis. Mult Scler Relat Disord 59:103669. https:\/\/doi.org\/10.1016\/j.msard.2022.103669","DOI":"10.1016\/j.msard.2022.103669"},{"key":"7283_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104081","volume":"67","author":"J Ravn","year":"2022","unstructured":"Ravn J, Jensen HB, Kant M, Andersen PB, G\u00f3ra MK, Sejbaek T (2022) Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis. MultSclerRelatDisord 67:104081. https:\/\/doi.org\/10.1016\/j.msard.2022.104081","journal-title":"MultSclerRelatDisord"},{"key":"7283_CR10","doi-asserted-by":"publisher","unstructured":"Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodr\u00edguez-Mart\u00edn E, Rold\u00e1n E, \u00c1lvarez-Cerme\u00f1o JC, Villar LM (2019) Factors associated with dimethyl fumarate-induced lymphopenia. J Neurol Sci 398:4\u20138. https:\/\/doi.org\/10.1016\/j.jns.2019.01.007.","DOI":"10.1016\/j.jns.2019.01.007"},{"issue":"9","key":"7283_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/obr.12869","volume":"20","author":"PC Angeles","year":"2019","unstructured":"Angeles PC, Robertsen I, Seeberg LT, Krogstad V, Skattebu J, Sandbu R, \u00c5sberg A, Hjelmesaeth J (2019) The influence of bariatric surgery on oral drug bioavailability in patients with obesity: a systematic review. Obes Rev 20(9):1299\u20131311. https:\/\/doi.org\/10.1111\/obr.12869","journal-title":"Obes Rev"},{"issue":"1","key":"7283_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1345\/aph.1Q414","volume":"46","author":"A Edwards","year":"2012","unstructured":"Edwards A, Ensom MH (2012) Pharmacokinetic effects of bariatric surgery. Ann Pharmacother 46(1):130\u2013136. https:\/\/doi.org\/10.1345\/aph.1Q414","journal-title":"Ann Pharmacother"},{"key":"7283_CR13","doi-asserted-by":"publisher","unstructured":"Kingma JS, Burgers DMT, Monpellier VM, Wiezer MJ, Bluss\u00e9 van Oud-Alblas HJ, Vaughns JD, Sherwin CMT, Knibbe CAJ (2021) Oral drug dosing following bariatric surgery: general concepts and specific dosing advice. Br J ClinPharmacol 87(12):4560\u20134576. https:\/\/doi.org\/10.1111\/bcp.14913","DOI":"10.1111\/bcp.14913"},{"key":"7283_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2210-4-22","volume":"4","author":"NH Litjens","year":"2004","unstructured":"Litjens NH, van Strijen E, van Gulpen C, Mattie H, van Dissel JT, Thio HB, Nibbering PH (2004) In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. BMC Pharmacol 4:22. https:\/\/doi.org\/10.1186\/1471-2210-4-22","journal-title":"BMC Pharmacol"},{"key":"7283_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jnutbio.2017.11.012","volume":"55","author":"AR Martins","year":"2018","unstructured":"Martins AR, Crisma AR, Masi LN, Amaral CL, Marzuca-Nassr GN, Bomfim LHM et al (2018) Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet. J Nutr Biochem 55:76\u201388. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.11.012","journal-title":"J Nutr Biochem"},{"issue":"11","key":"7283_CR16","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1074\/jbc.M116.770172","volume":"292","author":"H Nagao","year":"2017","unstructured":"Nagao H, Nishizawa H, Bamba T, Nakayama Y, Isozumi N, Nagamori S, Kanai Y, Tanaka Y, Kita S, Fukuda S, Funahashi T, Maeda N, Fukusaki E, Shimomura I (2017) Increased dynamics of tricarboxylic acid cycle and glutamate synthesis in obese adipose tissue: in vivo metabolic turnover analysis. J Biol Chem 292(11):4469\u20134483. https:\/\/doi.org\/10.1074\/jbc.M116.770172","journal-title":"J Biol Chem"},{"issue":"10","key":"7283_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nrgastro.2012.161","volume":"9","author":"J Aron-Wisnewsky","year":"2012","unstructured":"Aron-Wisnewsky J, Dor\u00e9 J, Clement K (2012) The importance of the gut microbiota after bariatric surgery. Nat Rev GastroenterolHepatol 9(10):590\u2013598. https:\/\/doi.org\/10.1038\/nrgastro.2012.161","journal-title":"Nat Rev GastroenterolHepatol"},{"issue":"3","key":"7283_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/03602532.2018.1497647","volume":"50","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang J, Wang R (2018) Gut microbiota modulates drug pharmacokinetics. Drug Metab Rev 50(3):357\u2013368. https:\/\/doi.org\/10.1080\/03602532.2018.1497647","journal-title":"Drug Metab Rev"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07283-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07283-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07283-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:40:51Z","timestamp":1715312451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07283-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["7283"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07283-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"22 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients signed informed consent regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}